Properties (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medication
|
| gptkbp:activeDuring |
leuprolide
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:availability |
widely available
|
| gptkbp:brand |
gptkb:Lupron_Injection
gptkb:Lupron_Depot gptkb:Lupron-PED |
| gptkbp:clinicalTrials |
prostate cancer treatment
endometriosis treatment precocious puberty treatment |
| gptkbp:contraindication |
pregnancy
breastfeeding hypersensitivity to leuprolide |
| gptkbp:dosageForm |
monthly injection
depot injection three-month injection |
| gptkbp:drugInterdiction |
gonadotropin-releasing hormone agonist
|
| gptkbp:endOfLife |
3 hours
|
| gptkbp:formulation |
injectable solution
|
| gptkbp:hasPopulation |
children
women adult men |
| https://www.w3.org/2000/01/rdf-schema#label |
Lupron
|
| gptkbp:interactsWith |
anticoagulants
other hormonal therapies |
| gptkbp:lastProduced |
1985
|
| gptkbp:manufacturer |
AbbVie
|
| gptkbp:nutritionalValue |
liver
|
| gptkbp:offers |
varies by dosage and insurance
|
| gptkbp:regulatoryCompliance |
prescription only
|
| gptkbp:researchAreas |
reproductive health
oncology hormonal therapies pediatric endocrinology |
| gptkbp:route |
intramuscular injection
subcutaneous injection |
| gptkbp:sideEffect |
fatigue
nausea weight gain headaches injection site reactions mood changes hot flashes decreased libido |
| gptkbp:storage |
refrigerate
|
| gptkbp:usedFor |
treating endometriosis
treating precocious puberty treating prostate cancer |
| gptkbp:waterManagement |
urine
|